115 related articles for article (PubMed ID: 3274376)
1. Frequency of diabetes-related complications in renal allograft recipients prospectively randomized to cyclosporine or azathioprine.
Pescovitz MD; Gruber SA; Ascher NL; Kruse LV; Najarian JS; Payne WD; Simmons RL; Sutherland DE; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1537-8. PubMed ID: 3274376
[No Abstract] [Full Text] [Related]
2. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
Sutherland DE; Fryd DS; Strand M; Ascher N; Simmons RL; Najarian JS
Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
[No Abstract] [Full Text] [Related]
3. Low-dose cyclosporine or azathioprine one year after renal transplantation.
Forwell MA; Bradley JA; Briggs JD; Brown MW; Junor BJ; Macpherson SG; Watson MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1858-9. PubMed ID: 3079052
[No Abstract] [Full Text] [Related]
4. Renal transplantation in diabetic patients: a survey of 100 cases.
Fonseca JA; Ianhez LE; Sabbaga E; Arap S
Transplant Proc; 1992 Oct; 24(5):1777-9. PubMed ID: 1412839
[No Abstract] [Full Text] [Related]
5. Kidney transplantation in diabetic patients.
Sutherland DE; Fryd DS; Payne WD; Ascher N; Simmons RL; Najarian JS
Transplant Proc; 1987 Apr; 19(2 Suppl 2):90-4. PubMed ID: 3551260
[No Abstract] [Full Text] [Related]
6. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
[No Abstract] [Full Text] [Related]
7. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
[No Abstract] [Full Text] [Related]
8. Deep venous thrombosis in patients undergoing renal transplantation--effects of cyclosporine A.
Brunkwall J; Bergqvist D; Bergentz SE; Bornmyr S; Husberg B
Transplant Proc; 1987 Feb; 19(1 Pt 2):1814. PubMed ID: 3274426
[No Abstract] [Full Text] [Related]
9. Quality of life on cyclosporine versus conventional therapy.
Simmons RG; Abress LK
Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
[No Abstract] [Full Text] [Related]
10. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
Gruber SA; Pescovitz MD; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Fryd DS
Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
[TBL] [Abstract][Full Text] [Related]
11. Pathology of two-year renal biopsies in cyclosporine and conventionally immunosuppressed renal transplants.
Santelli G; Hiesse C; Schovaert D; Fassi-Fihri S; Lantz O; Bensadoun H; Benoit G; Charpentier B; Martin E; Fries D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1674-6. PubMed ID: 2652548
[No Abstract] [Full Text] [Related]
12. Cyclosporine versus azathioprine in high risk cadaver kidney transplant recipients: a prospective randomized study.
Norman DJ; Wetzsteon P; Barry JM; Bennett WM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1845. PubMed ID: 3079046
[No Abstract] [Full Text] [Related]
13. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
15. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
Ebel H; Lange H
Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
[No Abstract] [Full Text] [Related]
16. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Serafinowicz A; Gaciong Z; Baçzkowska T; Durlik M; Lao M
Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
[No Abstract] [Full Text] [Related]
17. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
Pomer S; Daniel V; Dreikorn K; Röhl L
Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
[No Abstract] [Full Text] [Related]
18. A long-term prevention of diabetic nephropathy in a patient with type 1 diabetes after simultaneous pancreas and kidney transplantation.
Nyumura I; Honda K; Babazono T; Taneda S; Horita S; Teraoka S; Yamaguchi Y; Iwamoto Y; Oda H
Clin Transplant; 2009 Aug; 23 Suppl 20():54-7. PubMed ID: 19594598
[TBL] [Abstract][Full Text] [Related]
19. A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation.
De Vecchi A; Tarantino A; Montagnino G; Egidi F; Vegeto A; Berardinelli L; Ponticelli C
Transplant Proc; 1987 Feb; 19(1 Pt 3):1933-4. PubMed ID: 3079060
[No Abstract] [Full Text] [Related]
20. Late complications in kidney-pancreas transplant recipients.
Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Seaman DS; Huss E; Thistlethwaite JR
Transplant Proc; 1995 Dec; 27(6):3118. PubMed ID: 8539871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
